Cargando…

Lorcaserin and metabolic disease: weight‐loss dependent and independent effects

OBJECTIVE: Weight management pharmacotherapies can improve metabolic diseases through weight‐dependent and weight‐independent effects. Lorcaserin is a selective 5‐hydroxytryptamine 2C receptor agonist. The objective of this analysis is to quantify the relative contribution of weight loss to the trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bays, H., Perdomo, C., Nikonova, E., Knoth, R., Malhotra, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298312/ https://www.ncbi.nlm.nih.gov/pubmed/30574343 http://dx.doi.org/10.1002/osp4.296

Ejemplares similares

Lorcaserin for weight management
por: Taylor, James R, et al.
Publicado: (2013)

Effect of lorcaserin on weight reduction in persons with obstructive sleep apnea (OSA): a combined subgroup analysis from three randomized, controlled clinical trials
por: Fujioka, K., et al.
Publicado: (2019)

RF24 | PSUN95 Defining Predictors of Weight Loss Response to Lorcaserin
por: Gugger, Aristea Sideri, et al.
Publicado: (2022)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

Effect of lorcaserin in different age groups: a post hoc analysis of patients from the BLOOM, BLOSSOM and BLOOM‐DM studies
por: Fujioka, K., et al.
Publicado: (2019)

A randomized, open-label pilot of the combination of low-level laser therapy and lorcaserin for weight loss
por: Croghan, Ivana T., et al.
Publicado: (2016)

Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings after 12 week-treatment: Randomized Sub-study
por: Rebello, Candida, et al.
Publicado: (2018)

Lorcaserin: A novel antiobesity drug
por: Brashier, Dick B. S., et al.
Publicado: (2014)

Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention: A Randomized Clinical Trial
por: Hurt, Ryan T., et al.
Publicado: (2022)

Coadministration of lorcaserin and phentermine for weight management: A 12‐week, randomized, pilot safety study
por: Smith, Steven R., et al.
Publicado: (2017)

Lorcaserin for the treatment of obesity? A closer look at its side effects
por: DiNicolantonio, James J, et al.
Publicado: (2014)

The use of lorcaserin in the management of obesity: a critical appraisal
por: Bai, Bo, et al.
Publicado: (2010)

Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
por: Song, Eun-Ji, et al.
Publicado: (2023)

Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
por: Hurt, Ryan T, et al.
Publicado: (2018)

Lorcaserin improves glycemic control via a melanocortin neurocircuit
por: Burke, Luke K., et al.
Publicado: (2017)

Effects of lorcaserin on pre‐existing valvulopathy: A pooled analysis of phase 3 trials
por: Weissman, Neil J., et al.
Publicado: (2016)

Lorcaserin therapy for severe epilepsy of childhood onset: A case series
por: Tolete, Patricia, et al.
Publicado: (2018)

Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats
por: Price, Amanda E., et al.
Publicado: (2018)

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
por: Di Giovanni, Giuseppe, et al.
Publicado: (2020)

Lorcaserin Inhibit Glucose-Stimulated Insulin Secretion and Calcium Influx in Murine Pancreatic Islets
por: Jing, Muhan, et al.
Publicado: (2021)

Hypothesis: Amelioration of obesity‐induced cognitive dysfunction via a lorcaserin–betahistine combination treatment
por: dela Peña, Ike C., et al.
Publicado: (2022)

Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial
por: Johns, Sade E., et al.
Publicado: (2021)

Chronic Lorcaserin Treatment Reverses the Nicotine Withdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats
por: Zaniewska, Magdalena, et al.
Publicado: (2021)

Lorcaserin vs. Phentermine among non-surgical and surgical obese patients: Anthropometric, glycemic, lipid, safety and cost outcomes
por: Elhag, Wahiba, et al.
Publicado: (2019)

Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats
por: Gannon, Brenda M., et al.
Publicado: (2018)

Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis
por: Zeng, Hai, et al.
Publicado: (2019)

Characterization of the 5-HT(2C) receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity
por: Higgins, Guy A, et al.
Publicado: (2015)

Comment on: Metabolic surgery improves renal injury independent of weight loss: a meta-analysis
por: Martin, William P., et al.
Publicado: (2019)

GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
por: Sachs, Stephan, et al.
Publicado: (2023)

Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression
por: Wagner, Stefan, et al.
Publicado: (2022)

Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
por: Stefanski, Casey D., et al.
Publicado: (2020)

Low-Fat or Low Carb for Weight Loss? It Depends on Your Glucose Metabolism
por: Astrup, Arne, et al.
Publicado: (2017)

Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery
por: Chaiyasoot, Kusuma, et al.
Publicado: (2023)

Osteocalcin Is Independently Associated with C-Reactive Protein during Lifestyle-Induced Weight Loss in Metabolic Syndrome
por: Zimmermann, Silke, et al.
Publicado: (2021)

The metabolic effects of resumption of a high fat diet after weight loss are sex dependent in mice
por: Guerra-Cantera, Santiago, et al.
Publicado: (2023)

Metabolic adaptation to weight loss: implications for the athlete
por: Trexler, Eric T, et al.
Publicado: (2014)

Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes
por: Ferdinand, Keith C., et al.
Publicado: (2023)

Metabotypes of response to bariatric surgery independent of the magnitude of weight loss
por: Palau-Rodriguez, Magali, et al.
Publicado: (2018)

Interleukin-15 Treatment Induces Weight Loss Independent of Lymphocytes
por: Barra, Nicole G., et al.
Publicado: (2012)

Independent and Combined Effects of Dietary Weight Loss and Exercise on Leukocyte Telomere Length in Postmenopausal Women
por: Mason, Caitlin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v4ifpnomm7v5mrf7mmnj76m1ov